Depression linked to faster cognitive decline in older adults

A review of 34 studies confirms depression is linked to faster cognitive decline in older adults.

A review of 34 longitudinal studies, involving 71,244 older adults, has concluded that depression is associated with greater cognitive decline.

The study included people who presented with symptoms of depression as well as those that were diagnosed as clinically depressed, but excluded any who were diagnosed with dementia at the start of study.

Previous research has found that depression is associated with an increased dementia risk.

The researchers recommend that preventative measures such as exercising, practicing mindfulness, and undertaking recommended therapeutic treatments, such as Cognitive Behaviour Therapy, might help protect cognitive health.

While the review included some studies into anxiety, the numbers were insufficient to draw a conclusion.

https://www.eurekalert.org/pub_releases/2018-05/uos-dsu052318.php

Reference

John, A., Patel, U., Rusted, J., & Richards, M. Affective problems and decline in cognitive state in older adults: a systematic review and meta-analysis. | Psychological Medicine, 49(3), 353-365. Retrieved from https://www.cambridge.org/core/journals/psychological-medicine/article/affective-problems-and-decline-in-cognitive-state-in-older-adults-a-systematic-review-and-metaanalysis/5D529D177B003920ECC3A7280BAB7318

Related News

Aerobic exercise preserves brain volume and improves cognition in those with MCI

A study involving 35 adults with MCI found that those who exercised four times a week over a six-month period increased their volume of gray matter. But those who participated in aerobic exercise experienced significantly greater gains than those who just stretched, who also showed signs of white matter loss.

Aerobic activity included treadmill, stationary bike or elliptical training.

The study was presented at the annual meeting of the Radiological Society of North America (RSNA) in November, 2016.

Older adults' distractability can be used to help put a face to a name

One important reason for the greater cognitive problems commonly experienced as we age, is our increasing difficulty in ignoring distracting and irrelevant information. But it may be that in some circumstances that propensity can be used to help memory.

Exercise improves brain function in older adults with MCI

A small study has found that a 12-week exercise program significantly improved cognition in both older adults with MCI and those who were cognitively healthy, but that effect on blood flow in the brain was different in these two groups.

Lymphatic vessels critical to a healthy brain

Although first reported in 1816, the fact that the brain is surrounded by lymphatic vessels, which connect the brain and the immune system, was only rediscovered in 2015.

Impaired recovery from inflammation linked to Alzheimer's

Submitted by Fiona McPherson on Mon, 18 Aug 2014 - 14:55

Analyses of cerebrospinal fluid from 15 patients with Alzheimer's disease, 20 patients with mild cognitive impairment, and 21 control subjects, plus brain tissue from some of them, has found that those with Alzheimer’s had lower levels of a particular molecule involved in resolving inflammation. These ‘specialized pro-resolving mediators’ regulate the tidying up of the damage done by inflammation and the release of growth factors that stimulate tissue repair. Lower levels of these molecules also correlated with a lower degree of cognitive function.

Blood test predicts Alzheimer’s risk early

Submitted by Fiona McPherson on Wed, 10 Sep 2014 - 21:42

A five-year study involving 525 older adults (70+) found 46 had Alzheimer’s or aMCI and a further 28 went on to develop the conditions. The blood levels of 10 specific lipids predicted with more than 90% accuracy whether an individual would go on to develop either Alzheimer’s or aMCI within 2-3 years. The researchers speculate that the lower lipid levels could be an early indication that brain cells are beginning to lose their integrity and break down.

Tracking preclinical Alzheimer's progression

Submitted by Fiona McPherson on Wed, 17 Sep 2014 - 09:26

New research supports the classification system for preclinical Alzheimer’s proposed two years ago. The classification system divides preclinical Alzheimer's into three stages:

Stage 1: Levels of amyloid beta begin to decrease in the spinal fluid. This indicates that the substance is beginning to form plaques in the brain.

Stage 2: Levels of tau protein start to increase in the spinal fluid, indicating that brain cells are beginning to die. Amyloid beta levels are still abnormal and may continue to fall.

New biomarker shows Alzheimer's disease long before symptoms

Submitted by Fiona McPherson on Wed, 17 Sep 2014 - 15:51

Analysis of mitochondrial DNA (mtDNA) in the cerebrospinal fluid has found that both symptomatic Alzheimer’s patients and asymptomatic patients at risk of Alzheimer’s showed a significant decrease in levels of circulating cell-free mtDNA in the CSF. Patients with frontotemporal dementia did not display this.

Gene variation associated with brain atrophy in MCI

Submitted by Fiona McPherson on Tue, 23 Sep 2014 - 17:10

Analysis of data from 237 patients with mild cognitive impairment (mean age 79.9) has found that, compared to those carrying the ‘normal’ ApoE3 gene (the most common variant of the ApoE gene), the ApoE4 carriers showed markedly greater rates of shrinkage in 13 of 15 brain regions thought to be key components of the brain networks disrupted in Alzheimer’s.

http://www.eurekalert.org/pub_releases/2014-01/rson-gva010714.php

COPD associated with increased risk of MCI

Data from 1,425 cognitively healthy older adults (70-89) has found that a diagnosis of chronic obstructive pulmonary disease (COPD) was associated with an 83% greater risk of developing non-amnestic mild cognitive impairment. The greatest risk was among patients who had COPD for more than five years.

Over the study period, 230 (16%) developed amnestic MCI, 97 (7%) nonamnestic MCI, 27 (2%) MCI of unknown type, and 16 dementia (1%).